Decitabine may have immunomodulatory effects. Vasu et al show that decitabine significantly increases NKG2DL on AML blasts resulting in higher BI 836858–mediated ADCC postdecitabine when compared with predecitabine treatment. Professional illustration by Somersault18:24.